Candriam Equities L Biotechnology, R - Capitalisation
WKN A2DHUX | ISIN LU0942225912 | Fonds
Fonds
ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
---|---|---|---|---|---|---|
1 | LU1540961759 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD | +3,00 % | +18,70 % | 0,05 |
|
2 | LU1540962054 | HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD | +2,47 % | +19,53 % | 0,02 |
|
3 | LU0942225912 | Candriam Equities L Biotechnology, R - Capitalisation | +1,02 % | +20,60 % | -0,05 |
|
4 | LU0133360163 | Candriam Equities L Biotechnology, I - Capitalisation | +0,64 % | +20,42 % | -0,07 |
|
5 | LU2026682919 | Candriam Equities L Biotechnology, V2 - Capitalisation | -0,32 % | +20,47 % | -0,12 |
|
79 | LU0767968745 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating | -9,55 % | +12,17 % | -0,96 |
|
80 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | -13,11 % | +14,06 % | -1,09 |
|
81 | LU0415392595 | Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating | -13,72 % | +14,06 % | -1,13 |
|
82 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -32,96 % | +30,82 % | -1,14 |
|
83 | DE000A3DCA95 | BIT Biotech Opportunities S | -33,04 % | +30,80 % | -1,14 |
|